States Widen Generics Price-Fixing Lawsuit, Name Names

A multistate price-fixing lawsuit against generic drugmakers should be dramatically expanded to target more drugs, more companies and, for the first time, individual company executives, the attorneys general who filed the litigation told a federal court.

The attorneys general asked the U.S. District Court for the Eastern District of Pennsylvania to amend their original December lawsuit to increase the number of drugs involved from two to 15 and the number of companies from six to 18, Connecticut AG George Jepsen said.

The attorneys general also seek to add Mylan President Rajiv Malik and Emcure CEO Satish Mehta as individually-named defendants in the civil antitrust case, Jepsen said.